Jubilant Organosys has signed a $51m, four-year research and manufacturing deal with an unnamed US company. The company is in discussions to expand the contract, which could be extended by a further five years. R Sankaraiah, Jubilant's Executive Director of Finance, said the deal takes Jubilant;s CRAMS order book over $1bn.
Money Control
Tuesday, 24 August 2010
Jubilant signs CRAMS deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment